Results 271 to 280 of about 282,907 (338)

Does Left Atrial Size and E/e' Predict Outcomes in Hypertrophic Cardiomyopathy? [PDF]

Echocardiography
Tillson B, Lord S, Eggett C.
europepmc   +1 more source

Cardiac fibrosis induced by high‐fat diet in ApoE‐deficient male mice is exacerbated by genetic deletion of PACAP–PAC1 signaling

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
Abstract Cardiac fibrosis is characterized by an excessive accumulation of extracellular matrix proteins and occurs in a variety of cardiac diseases, such as the highly prevalent syndrome heart failure with preserved ejection fraction (HFpEF) and other cardiac disorders.
J. M. Schubart, M. K. H. Schaefer, G. A. Bonaterra, L. Mey, H. Schwarzbach, S. Pankuweit, F. Ausbuettel, L. E. Eiden, S. Weyand, E. Weihe, R. Kinscherf, C. Waechter   +11 more
wiley   +1 more source

Clinical characteristics of 41 children with hypertrophic cardiomyopathy: A single-center retrospective study. [PDF]

J Int Med Res
Li SG, Wei CQ, Su DY, Chen C, Qin SY, Ye BB, Pang YS.   +6 more
europepmc   +1 more source

Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten. [PDF]

JACC Heart Fail
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT.   +9 more
europepmc   +1 more source

Left Ventricular Sarcoma Causing Dynamic Outflow Tract Obstruction and Cardiogenic Shock: A Case Report

Case Reports in Critical Care, Volume 2026, Issue 1, 2026.
Background Primary cardiac sarcomas are rare and aggressive tumors that often present with nonspecific symptoms, typically diagnosed at advanced stages. Obstruction of the left ventricular outflow tract (LVOT) due to these tumors is an exceptionally rare and life‐threatening complication.
Tomás de la Barra, Mariana Navarro, Pablo Regueira, Aníbal Zamorano, Marlon Ponce, Mario Portilla, Pablo Salazar, Tomas Regueira, Lipi Buch   +8 more
wiley   +1 more source

Echocardiographic Mitral Valve Fibroelastoma in a Patient With Hypertrophic Cardiomyopathy. [PDF]

JACC Case Rep
Le Q, Gilman JP, Hsieh JJ, Nuvvula S, Bhuiya T, Wharton R, Makaryus JN.   +6 more
europepmc   +1 more source

Identification of Two Rare Variants in Iranian Families With Familial Sudden Cardiac Death

International Journal of Genomics, Volume 2026, Issue 1, 2026.
Cellular action potential is characterized by a particular sequence of depolarizing and repolarizing ion currents regulated by ion channels. Genetic mutations in these channels disrupt the essential movement of ions, such as Na+, Ca++, and K+, across the cell membrane, leading to dangerous arrhythmias and sudden cardiac death (SCD).
Mahsa Tahmasebivand, Sepideh Mehvari, Fatemeh Ghodratpour, Hamidreza Khoram Khorshid, Reza Malekzadeh, Reza Najafipour, Yasser Riazalhosseini, Mark Lathrop, Hossein Najmabadi, Kimia Kahrizi, Neetu Rawal   +10 more
wiley   +1 more source

T-Cell-Driven Immunopathology and Fibrotic Remodeling in Hypertrophic Cardiomyopathy: A Translational Scoping Review. [PDF]

Cells
Menezes Junior ADS, de Oliveira HL, de Lima KBA, Botelho SM, Wastowski IJ.   +4 more
europepmc   +1 more source

Yixiao Formula Suppresses Myocardial Fibrosis Through UpregulatingmiR‐133a and Downregulating TGF‐β/Smads Signal Molecules

Journal of Diabetes Research, Volume 2026, Issue 1, 2026.
Background Yixiao formula (YXF), a traditional Chinese herbal medicine, has demonstrated clinical efficacy in alleviating symptoms of diabetic cardiomyopathy (DCM). The therapeutic mechanism underlying YXF′s effects on DCM remains poorly understood. Myocardial fibrosis is a key pathogenic mechanism in DCM, and previous studies have indicated that miR ...
Qiyao Zhao, Yalu Wen, Honghui Wu, Jiaoyue Li, Yunpeng Luo, Ping Li, Ye Zhang, Chaoyue Hu, Jukai Huang, Li Zhang, Xiaohui Yang, Huantian Cui   +11 more
wiley   +1 more source

Cardiogenic Shock in Hypertrophic Cardiomyopathy Treated With Mavacamten and Clarithromycin. [PDF]

JACC Case Rep
Alabdaljabar MS, Desai M, Geske JB.
europepmc   +1 more source